Early Restoration Of Blood Flow Following A Heart Attack Shown To Improve Long-Term Survival For Patients

DALLAS, April 28 -- Getting immediate vessel-opening treatment after a heart attack can help you live longer than previously believed, say researchers in a study published in today's Circulation: Journal of the American Heart Association.

While it's well known that immediately restoring blood flow to the heart following a heart attack provides a short-term benefit, this study is the first to demonstrate that those with early restored blood flow show a significant statistical improvement in survival rates beyond the first 30 days following the heart attack.

The researchers acknowledge previous studies that showed that vessel-opening treatment is better than placebo up to 30 days following the treatment. "But beyond 30 days, the survival curves have been consistently parallel (the same) for the following 1 to 5 years indicating no further treatment advantage," the authors write.

Most people who die of a heart attack do so in the first 24 hours. Immediate restoration of blood flow to the heart after a heart attack -- a process called reperfusion -- is critically important to preserving the main pumping chamber of the heart. The researchers say their study provides evidence strengthening the need for early arrival at a hospital for treatment that can greatly improve chances for a good recovery.

"Successful early reperfusion provides patients with an advantage that continues to increase well beyond the first month after a heart attack," says lead author Allan M. Ross, M.D., director of the Cardiovascular Research Institute at George Washington University in Washington, D.C. "Although cost analysis was not a component of this study, the substantial additional later benefits should be taken into account in consideration of the cost-effectiveness of aggressive treatment strategies."

The researchers found that preserving the function of the left ventricle -- the heart's main pumping chamber -- through

Contact: Brian Henry
American Heart Association

Page: 1 2 3

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early treatment can prevent severe vision loss in premature infants
10. Early hominids may have behaved more human than we had thought
11. Early infection and rejection detection

Post Your Comments:

(Date:3/2/2020)... ... 2020 , ... Nominations are now being accepted for the 2020 Women ... (SIA) and SecureIDNews and co-presented with sponsors IDEMIA , ... of this year’s Women in Biometrics Awards will be honored at the 2020 SIA ...
(Date:2/28/2020)... ... February 27, 2020 , ... An upcoming episode of ... for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s Disease (Crohn’s), and ... on a novel platform developed by Deka Biosciences, Inc. (Deka Biosciences), that will ...
(Date:2/26/2020)... ... ... Renowned eye surgical practice led by Steven J. Dell, MD, Dell ... post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering this technology in November ... is also currently involved in the latest LAL FDA study. , The RxSight™ ...
Breaking Biology News(10 mins):
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is ... 2020 in Las Vegas. The course is hands on involving real patients and stem ... few years, the Comprehensive Stem Cell Training Course has received rave reviews from attendees, ...
(Date:2/5/2020)... DEERFIELD BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... is an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to ... on patients’ lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype ... a best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... announced the release of Genedata Expressionist ® 13.5 at the 2020 ... Multi-Attribute Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout ...
Breaking Biology Technology:
Cached News: